40+ years representing leading global life sciences companies
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
Learn More
Practices
Practices
- Corporate
- Litigation
- Regulatory
- Intellectual Property
- Band 1 for US Nationwide, California and Massachusetts Life Sciences in 2022 — Chambers
Tier 1 for Healthcare: Life Sciences in 2021 — Legal 500 US
Consistently rank #1 for global biotech & pharma licensing — BioPharm Insight
- #1 in issuer-side life sciences IPOs since 2000
- #1 for biotech and pharma venture financings for the last decade, including in 2018 — PitchBook
- Top 4 law firm for US biotech & pharma M&A volume since 2016 (Mergermarket + Pitchbook)
- "Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences
- Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies
Read more
- Defended more life sciences companies in shareholder litigation filed over the past ten years than any other firm
- Achieved groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court
- Complete wins in commercially significant drug ownership and licensing disputes
- Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies
- Defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Food, Drug and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers
- Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies
- Team includes 5 Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers
- Ranked #4 Most Innovative Law Firm by the Financial Times – recognized for Protecting Clients Business for litigating on behalf of our clients
Read more
- Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking
- Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors
- As connectors to the ecosystem, we counsel clients on how to launch innovative products and services
- Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience
- Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers
- Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications
- Market leader in life sciences — #1 in IPOs, M&A transactions, venture financings and licensing
Read more
- 90+ person life sciences patent team across the US and UK (90% hold PhDs)
- The largest life sciences patent practice in the US
- 31,000+ Patents currently under our management worldwide
- 1,000+ IP due diligence reviews in life sciences deals/transactions
- One of the most active IP litigation practices in the US with 500+ cases in the last 5 years
- Complete wins in commercially significant drug ownership and licensing disputes
- Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies
- Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names
- "Patent Strategy and Management Firm of the Year" Honoree – LMG Life Sciences (2018)
Read more
According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.
- LMG Life Sciences
Cooley Rx
A virtual series focused on the life sciences and healthcare sectors
Learn more
Life Sciences & Healthcare Innovation Hub
Comprehensive resource for key stakeholders across the global life sciences and healthcare industry
Visit hub
Group Contacts
Yiming Liu
Partner in Charge – Shanghai
Shanghai, Hong Kong
ViewHide related contacts
+-
Listing Returned 0 Results.
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.